scispace - formally typeset
K

Katrina Podsypanina

Researcher at PSL Research University

Publications -  36
Citations -  9150

Katrina Podsypanina is an academic researcher from PSL Research University. The author has contributed to research in topics: PTEN & Cancer. The author has an hindex of 22, co-authored 35 publications receiving 8805 citations. Previous affiliations of Katrina Podsypanina include Kettering University & Curie Institute.

Papers
More filters
Journal ArticleDOI

Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice.

TL;DR: An animal model has been developed in which the absence of Pten collaborates with Wnt-1 to induce ductal carcinoma in the mammary gland, useful for testing therapies specific for tumors deregulated in the PTEN/PI3K/AKT pathway.
Journal ArticleDOI

Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation

TL;DR: The cellular and environmental context can lead to differential IL-6/pStat3 signaling and a dependency on this cytokine and transcription factor for migration, invasion and tumorigenesis.
Journal ArticleDOI

Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction

TL;DR: A three-dimensional culture system is developed to analyze the responses of primary mouse mammary epithelial cells to the induction and deinduction of oncogenes and shows cells in the surviving spheres retain the ability to respond to reinduction and thus may represent the type of cells that give rise to recurrent tumors.
Journal ArticleDOI

DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice.

TL;DR: The results indicate that DNA mismatch repair deficiency can accelerate endometrial tumorigenesis in Pten heterozygous mice and suggests that loss of the wild-type Pten allele is involved in the development/progression of tumors in this setting.
Journal ArticleDOI

Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation

TL;DR: This in vivo study uncovers an unexpected effect of ErbB2 activation previously known for its prosurvival roles, and suggests that protection of the ATM-mediated DDR-p53 signaling pathway may be important in breast cancer prevention.